Suppr超能文献

治疗前 F-FDG 正电子发射断层扫描/计算机断层扫描在小儿神经母细胞瘤中的预后意义。

Prognostic significance of pretreatment F-FDG positron emission tomography/computed tomography in pediatric neuroblastoma.

机构信息

Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., MLC 5031, Cincinnati, OH, 45229, USA.

Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

出版信息

Pediatr Radiol. 2021 Jul;51(8):1400-1405. doi: 10.1007/s00247-021-05005-y. Epub 2021 Feb 25.

Abstract

BACKGROUND

F-2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) shows tumor activity in most neuroblastomas, but the role of F-FDG PET/CT in neuroblastoma remains to be defined.

OBJECTIVE

This study explored the prognostic significance of F-FDG PET in newly diagnosed neuroblastic tumors.

MATERIALS AND METHODS

This retrospective study reviewed all F-FDG PET/CT examinations performed for a new diagnosis of suspected neuroblastoma. MYCN amplification status, tumor recurrence and survival were abstracted from the medical record. Primary tumors were manually segmented to measure maximum standardized uptake value (SUV), mean standardized uptake value (SUV), tumor volume and total lesion glycolysis. Univariate and multivariable analyses using Cox proportional hazards regression testing assessed the predictive performance of PET indices for event-free survival and overall survival with thresholds determined using receiver operating characteristic curve analysis.

RESULTS

Fifty-five children were included, with a median age of 2.9 years (interquartile range [IQR] 1.8-3.0 years). SUV, tumor volume and total lesion glycolysis were higher in MYCN-amplified tumors (P=0.012, P<0.0001, P<0.0001, respectively) and in higher International Neuroblastoma Risk Group (INRG) stages (P=0.0008, P=0.0017, P=0.0017, respectively). After adjusting for age, tumor SUV (P=0.028) and SUV (P=0.045) were associated with overall survival. An SUV threshold of 4.77 (P=0.028) best predicted overall survival, with median overall survival of 2,604 days (SUV>4.77) vs. >2,957 days (SUV≤4.77). No PET parameters were independently significantly associated with overall survival or event-free survival after controlling for MYCN status, stage or treatment risk stratification.

CONCLUSION

Tumor metabolic activity is higher in higher-stage MYCN-amplified neuroblastic tumors. Higher SUV and SUV were associated with worse overall survival but were not independent of other prognostic markers.

摘要

背景

氟-2-脱氧葡萄糖(FDG)正电子发射断层扫描(PET)显示大多数神经母细胞瘤的肿瘤活性,但 F-FDG PET/CT 在神经母细胞瘤中的作用仍有待确定。

目的

本研究探讨了 F-FDG PET 在新诊断的神经母细胞瘤中的预后意义。

材料和方法

这项回顾性研究回顾了所有为疑似神经母细胞瘤新诊断而进行的 F-FDG PET/CT 检查。从病历中提取 MYCN 扩增状态、肿瘤复发和生存情况。手动分割原发肿瘤以测量最大标准化摄取值(SUV)、平均标准化摄取值(SUV)、肿瘤体积和总病变糖酵解。使用 Cox 比例风险回归测试进行单变量和多变量分析,使用受试者工作特征曲线分析确定的阈值评估 PET 指数对无事件生存和总生存的预测性能。

结果

共纳入 55 名儿童,中位年龄为 2.9 岁(四分位距 [IQR] 1.8-3.0 岁)。MYCN 扩增肿瘤的 SUV、肿瘤体积和总病变糖酵解值较高(P=0.012、P<0.0001、P<0.0001,分别),国际神经母细胞瘤风险组(INRG)分期较高(P=0.0008、P=0.0017、P=0.0017,分别)。在校正年龄后,肿瘤 SUV(P=0.028)和 SUV(P=0.045)与总生存相关。SUV 阈值为 4.77(P=0.028)时,总生存最佳,SUV>4.77 的中位总生存时间为 2604 天(SUV>4.77),SUV≤4.77 的中位总生存时间为>2957 天。在控制 MYCN 状态、分期或治疗风险分层后,没有 PET 参数与总生存或无事件生存独立显著相关。

结论

高分期 MYCN 扩增神经母细胞瘤的肿瘤代谢活性更高。较高的 SUV 和 SUV 与较差的总生存相关,但与其他预后标志物无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验